DiCE Molecules’ $80 Million Series C

Wilson Sonsini Goodrich & Rosati and Fenwick & West LLP advised DiCE Molecules on the deal. DiCE Molecules, a biopharmaceutical company leveraging its proprietary DNA-encoded library…